American College of Cardiology

FEBRUARY 28, 2024

In this week’s View, Dr. Eagle covers coronary calcium scores and how they predict ASCVD risk in the presence of left main disease and diabetes.

Diabetes 50

Diabetes Tricuspid Article 50

Frontiers in Cardiovascular Medicine

NOVEMBER 17, 2024

The level of hemoglobin (Hb) had a weak negative linear correlation with NT-pro-BNP (log-transform, r = 0.30, P < 0.0001) and a positively correlation with the tricuspid annular plane systolic excursion (TAPSE)/pulmonary arterial systolic pressure (PASP) ratio (r = 0.44, P < 0.0001).

Preserved Ejection Fraction 59

Preserved Ejection Fraction Heart Failure Tricuspid Atrial Fibrillation 59

CardiacWire

JUNE 30, 2024

TR Options – H1 brought the FDA approvals of Edwards’ EVOQUE transcatheter tricuspid valve replacement system and Abbott’s TriClip tricuspid edge-to-edge repair (TEER) system, giving US interventionalists the options to repair or replace the tricuspid valve for the first time.

Tricuspid 59

Tricuspid Reimbursement Medicare Electrophysiology 59

Heart BMJ

DECEMBER 15, 2023

Results While undergoing heart failure treatment, 559 (81.5%) patients improved systolic function ( LVEF >0%), with 100 (14.6%) being super responders defined by LVEF improvement >20%. Mortality incidence rates differed with LVEF improvement ( LVEF <0% vs LVEF >0%, 8.3 per 100 person years, p=0.012).

Heart Failure 45

Heart Failure Outpatient Tricuspid Cardiomyopathy 45

Dr. Smith's ECG Blog

JANUARY 1, 2024

His medical history includes hypertension, a decade-long battle with diabetes, ischemic heart disease, a coronary bypass graft surgery ten years ago, a diagnosis of congestive heart failure for the last five years, and a prior ICD implantation five years ago. Aslanger's discussion relates to the recognition of intermittent Cannon waves.

Tachycardia 111

Tachycardia Blog Ischemia Heart Failure 111

Cardiometabolic Health Congress

JULY 17, 2024

Edwards EVOQUE Tricuspid Valve Replacement System (Approved: 02/01/2024) This system provides a novel approach to tricuspid valve replacement, potentially benefiting patients with tricuspid regurgitation without open-heart surgery. March 2024 FDA Approvals: A Milestone Month for Cardiorenal metabolic Health 1.

Tricuspid 59

Tricuspid Open-Heart Surgery Kidney Disease Pediatrics 59

Circulation

NOVEMBER 11, 2024

All patients were prospectively followed for development of new outcome/cardiac events which included hospitalization for acute HF, CVS-related death, heart transplantation, and also diabetic complications. Circulation, Volume 150, Issue Suppl_1 , Page A4138589-A4138589, November 12, 2024.

Coronary Artery Disease 40

Coronary Artery Disease Diabetes Heart Transplant Tricuspid 40